Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Gumbiner

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The American Journal of Physiology|March 1, 1996
Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylationB Gumbiner, J F Mucha, J E Lindstrom, et al.
Metabolism: Clinical and Experimental|October 1, 1992
Role of impaired intracellular glucose metabolism in the insulin resistance of agingB Gumbiner, A W Thorburn, T M Ditzler, et al.
Diabetes Care|January 1, 1993
Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trialR R Henry, B Gumbiner, T Ditzler, et al.
Diabetes|July 1, 1994
Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDMK S Polonsky, B Gumbiner, D Ostrega, et al.
Clinical and Translational Science|November 19, 2016
A Phase I Randomized Study of a Specifically Engineered, pH-Sensitive PCSK9 Inhibitor RN317 (PF-05335810) in Hypercholesterolemic Subjects on Statin TherapyM Levisetti, T Joh, H Wan, et al.
Diabetes|December 1, 1989
Effects of aging on insulin secretionB Gumbiner, K S Polonsky, W F Beltz, et al.
The Journal of Biological Chemistry|May 3, 1996
Desmosomal cadherin binding domains of plakoglobinL L Witcher, R Collins, S Puttagunta, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1990
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitusB Gumbiner, K S Polonsky, W F Beltz, et al.
Diabetes Care|September 4, 1998
Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study GroupJ B Buse, B Gumbiner, N P Mathias, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Lithium pharmacokinetics in the obeseR A Reiss, C E Haas, S D Karki, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The American Journal of Physiology|March 1, 1996
Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylationB Gumbiner, J F Mucha, J E Lindstrom, et al.
Metabolism: Clinical and Experimental|October 1, 1992
Role of impaired intracellular glucose metabolism in the insulin resistance of agingB Gumbiner, A W Thorburn, T M Ditzler, et al.
Diabetes Care|January 1, 1993
Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trialR R Henry, B Gumbiner, T Ditzler, et al.
Diabetes|July 1, 1994
Alterations in immunoreactive proinsulin and insulin clearance induced by weight loss in NIDDMK S Polonsky, B Gumbiner, D Ostrega, et al.
Clinical and Translational Science|November 19, 2016
A Phase I Randomized Study of a Specifically Engineered, pH-Sensitive PCSK9 Inhibitor RN317 (PF-05335810) in Hypercholesterolemic Subjects on Statin TherapyM Levisetti, T Joh, H Wan, et al.
Diabetes|December 1, 1989
Effects of aging on insulin secretionB Gumbiner, K S Polonsky, W F Beltz, et al.
The Journal of Biological Chemistry|May 3, 1996
Desmosomal cadherin binding domains of plakoglobinL L Witcher, R Collins, S Puttagunta, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 1990
Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitusB Gumbiner, K S Polonsky, W F Beltz, et al.
Diabetes Care|September 4, 1998
Troglitazone use in insulin-treated type 2 diabetic patients. The Troglitazone Insulin Study GroupJ B Buse, B Gumbiner, N P Mathias, et al.
Clinical Pharmacology and Therapeutics|April 1, 1994
Lithium pharmacokinetics in the obeseR A Reiss, C E Haas, S D Karki, et al.
Pageof 6